First Financial: Earnings Fuel Rising Potential, Buy
seekingalpha.com
Want to monitor IBIO?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor IBIOiBio is a global leader in plant-based biologics manufacturing. Its FastPharming® System combines vertical farming, automated hydroponics, and novel glycosylation technologies to rapidly deliver high-quality monoclonal antibodies, vaccines, bioinks and other proteins. iBio is developing proprietary products on the FastPharming Platform, which include biopharmaceuticals for the treatment of fibrotic and infectious diseases, amongst others.